Mar 25, 2015 · Familiarity with designer drugs can help clinicians recognize common adverse reactions and life-threatening consequences. This article will focus on three newer designer drugs: substituted cathinones (commonly referred to as “bath salts”), synthetic cannabinoids (SCs; e.g., “Spice”), and synthetic hallucinogens (e.g., “N-bomb”).
Routine inquiry about designer drug use is likely prudent, particularly among patients with a history of SUD, those who are undergoing mandated urine testing (e.g., criminal justice supervisees), or among those who have reported a history of designer drug use of a different chemical class . Different classes of designer drugs may be used concurrently, which could increase the incidence of adverse effects and …
REVIEW Open Access Designer drugs 2015: assessment and management Michael F Weaver1*, John A Hopper2 and Erik W Gunderson3 Abstract Recent designer drugs, also known as “legal highs,” include substituted cathinones (e.g., mephedrone, methylone,
Abuse of designer drugs is especially high among young adults, fre- quently leading to addiction, which can cause severe adverse effects and ultimately leading to economic burden, crimes and
TY – JOUR. T1 – Designer drugs 2015. T2 – Addiction science & clinical practice. AU – Weaver, Michael F. AU – Hopper, John A. AU – Gunderson, Erik W.
Newer designer drugs such as synthetic cannabinoids and bath salts are not detected by routine drug screening.
“Clinicians should keep designer drugs in mind when evaluating substance use in young adults or in anyone presenting with acute neuropsychiatric complaints. Treatment of acute intoxication involves supportive care targeting manifesting signs and symptoms” ( Weaver, Hopper, & Gunderson, 2015 ).
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances.pdf Office of Quality, Planning & Research. (2015).
Moved Permanently. The document has moved here.
This course familiarizes users with designer drugs, known as “legal highs,” summarizes common effects of these drugs, and provides treatment recommendations. Objectives: a. Discuss the epidemiology of emerging designer drugs. b. Name at least one designer drug in each of the drug classes: stimulants, cannabinoids, and hallucinogens.
Schedule I classification indicates a drug has no currently accepted medical use and a high potential for abuse (Office of National Drug Control Policy 2015 Office of National Drug Control Policy. 2015. Synthetic drugs (a.k.a. K2, Spice, Bath Salts, etc.).
In the United States, around 200-300 new designer drugs were identified between 2009-2014. These drugs are often distributed in night clubs, parties, and raves. Aside from their many detrimental effects on the body, these drugs have an added danger and lethality.